Building the internet's immune system.

What we do

AegisQ is the first cybersecurity platform that implements a biological immune architecture as working production technology — not as a marketing metaphor. T-Cell and B-Cell ML detectors sit on a Pub/Sub lymphatic system, trained by a Vertex AI bone-marrow pipeline. When one tenant learns a new threat, every tenant gets the antibody. The federated platform covers four surfaces today: runtime security, executive operations, AI-generated code, and software + physical AI governance.

We sell to engineering and platform-security teams: CISOs, AppSec leads, platform engineers, and founders running everything alone. Customers can self-serve the SaaS, or hand operation to a certified AegisQ MSSP partner — partners deliver managed AegisQ services to their customers; AegisQ does not sell managed services directly.

Founder

Jeff Grayson founded AegisQ in June 2025 after a career protecting Fortune 500 environments. He's the first named inventor on all 14 active provisional patents covering the platform, a regular at QSecDef (Quantum Security & Defence) weekly events, and advises companies on AI risk independently of his AegisQ role. Reach him on LinkedIn.

Where we're going

AegisQ Security is in general availability today. AI Sentinel is in early access (v3.4.0) and is the only platform we know of that governs both software AI agents (LLMs, LangChain, CrewAI) and physical AI systems (collaborative arms, AMRs, humanoids, surgical robots, drones) under one compliance framework. Helm and CodeShield are in beta. The MSSP partner program is live — partners can structure their offerings around three operational tiers (monitoring-only, 24×5, 24×7 fully managed).

The longer arc: quantum-resistant blockchain logging on the H2 2026 roadmap, the federated platform expanding to four more product surfaces over 2026–2028, and an agent-aware detection layer (AIDR) jointly with AI Sentinel to defend against autonomous adversaries.

Company facts